{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:10:39Z","timestamp":1789074639733,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong","doi-asserted-by":"crossref","award":["2021A1515011537"],"award-info":[{"award-number":["2021A1515011537"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10549-023-06876-5","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:07:26Z","timestamp":1676592446000},"page":"437-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation"],"prefix":"10.1007","volume":"198","author":[{"given":"Han","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZiShen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoze","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3377-3099","authenticated-orcid":false,"given":"Guozhu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"6876_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"6876_CR2","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20):1938\u20131948","journal-title":"N Engl J Med"},{"issue":"9804","key":"6876_CR3","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707\u20131716","journal-title":"Lancet"},{"issue":"12","key":"6876_CR4","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/labinvest.2012.140","volume":"92","author":"L Ellmann","year":"2012","unstructured":"Ellmann L, Joshi MB, Resink TJ, Bosserhoff AK, Kuphal S (2012) BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells. Lab Investig 92(12):1788\u20131800","journal-title":"Lab Investig"},{"issue":"21","key":"6876_CR5","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1046\/j.1432-1327.2000.01737.x","volume":"267","author":"DJ Smit","year":"2000","unstructured":"Smit DJ, Smith AG, Parsons PG, Muscat GE, Sturm RA (2000) Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur J Biochem 267(21):6413\u20136422","journal-title":"Eur J Biochem"},{"issue":"6","key":"6876_CR6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/0896-6273(93)90231-F","volume":"11","author":"H Fujii","year":"1993","unstructured":"Fujii H, Hamada H (1993) A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages. Neuron 11(6):1197\u20131206","journal-title":"Neuron"},{"issue":"4","key":"6876_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/labinvest.2013.2","volume":"93","author":"M Sakaeda","year":"2013","unstructured":"Sakaeda M, Sato H, Ishii J, Miyata C, Kamma H, Shishido-Hara Y, Shimoyamada H, Fujiwara M, Endo T, Tanaka R et al (2013) Neural lineage-specific homeoprotein BRN2 is directly involved in TTF1 expression in small-cell lung cancer. Lab Investig 93(4):408\u2013421","journal-title":"Lab Investig"},{"issue":"3","key":"6876_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/pin.12042","volume":"63","author":"J Ishii","year":"2013","unstructured":"Ishii J, Sato H, Sakaeda M, Shishido-Hara Y, Hiramatsu C, Kamma H, Shimoyamada H, Fujiwara M, Endo T, Aoki I et al (2013) POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer. Pathol Int 63(3):158\u2013168","journal-title":"Pathol Int"},{"issue":"13\u201314","key":"6876_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1101\/gad.314815.118","volume":"32","author":"YH Huang","year":"2018","unstructured":"Huang YH, Klingbeil O, He XY, Wu XS, Arun G, Lu B, Somerville T, Milazzo JP, Wilkinson JE, Demerdash OE et al (2018) POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev 32(13\u201314):915\u2013928","journal-title":"Genes Dev"},{"issue":"1","key":"6876_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/2159-8290.CD-15-1263","volume":"7","author":"JL Bishop","year":"2017","unstructured":"Bishop JL, Thaper D, Vahid S, Davies A, Ketola K, Kuruma H, Jama R, Nip KM, Angeles A, Johnson F et al (2017) The master neural transcription factor BRN2 is an androgen receptor-suppressed driver of neuroendocrine differentiation in prostate cancer. Cancer Discov 7(1):54\u201371","journal-title":"Cancer Discov"},{"key":"6876_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.03.001","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhou C, Li X, Barnes SD, Mu P (2020) Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.001","journal-title":"Cancer Cell"},{"issue":"5\u20136","key":"6876_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1101\/gad.314633.118","volume":"33","author":"K Herbert","year":"2019","unstructured":"Herbert K, Binet R, Lambert JP, Louphrasitthiphol P, Kalkavan H, Sesma-Sanz L, Robles-Espinoza CD, Sarkar S, Suer E, Andrews S et al (2019) BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma. Genes Dev 33(5\u20136):310\u2013332","journal-title":"Genes Dev"},{"issue":"15_Supplement","key":"6876_CR13","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1158\/1538-7445.AM2015-2101","volume":"75","author":"MA Rahman","year":"2015","unstructured":"Rahman MA, Liess L, Lellahi MS, Gjerde CH, Saed HS, Mutlu E, Zhu H, Wang J, Enger P\u00d8 (2015) Abstract 2101: the transcription factor POU3F2 is expressed in human gliomas and promotes tumorigenesis in vivo. Cancer Res (Chicago, Ill.) 75(15_Supplement):2101","journal-title":"Cancer Res (Chicago, Ill.)"},{"issue":"2","key":"6876_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV et al (2018) An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173(2):400\u2013416","journal-title":"Cell"},{"issue":"9","key":"6876_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41419-020-02977-x","volume":"11","author":"J Zheng","year":"2020","unstructured":"Zheng J, Wang B, Zheng R, Zhang J, Huang C, Zheng R, Huang Z, Qiu W, Liu M, Yang K et al (2020) Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1\/USP44 combination in glioma cells. Cell Death Dis 11(9):758","journal-title":"Cell Death Dis"},{"issue":"W1","key":"6876_CR16","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45(W1):W98\u2013W102","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"6876_CR17","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.bcp.2010.06.039","volume":"80","author":"A Deorukhkar","year":"2010","unstructured":"Deorukhkar A, Krishnan S (2010) Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol 80(12):1904\u20131914","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"6876_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","volume":"24","author":"K Bhat","year":"2013","unstructured":"Bhat K, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD et al (2013) Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 24(3):331\u2013346","journal-title":"Cancer Cell"},{"key":"6876_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.662840","volume":"11","author":"C Galeaz","year":"2021","unstructured":"Galeaz C, Totis C, Bisio A (2021) Radiation resistance: a matter of transcription factors. Front Oncol 11:662840","journal-title":"Front Oncol"},{"key":"6876_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fmolb.2014.00024","volume":"1","author":"R Baskar","year":"2014","unstructured":"Baskar R, Dai J, Wenlong N, Yeo R, Yeoh KW (2014) Biological response of cancer cells to radiation treatment. Front Mol Biosci 1:24","journal-title":"Front Mol Biosci"},{"issue":"4","key":"6876_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/leu.2010.6","volume":"24","author":"LJ Mah","year":"2010","unstructured":"Mah LJ, El-Osta A, Karagiannis TC (2010) GammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 24(4):679\u2013686","journal-title":"Leukemia"},{"issue":"1","key":"6876_CR22","first-page":"85","volume":"40","author":"Y Guo","year":"2012","unstructured":"Guo Y, Zhu XD, Qu S, Li L, Su F, Li Y, Huang ST, Li DR (2012) Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks. Int J Oncol 40(1):85\u201392","journal-title":"Int J Oncol"},{"issue":"3","key":"6876_CR23","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s13277-014-2820-1","volume":"36","author":"B Yang","year":"2015","unstructured":"Yang B, Yang E, Liao H, Wang Z, Den Z, Ren H (2015) ARNT2 is downregulated and serves as a potential tumor suppressor gene in non-small cell lung cancer. Tumour Biol 36(3):2111\u20132119","journal-title":"Tumour Biol"},{"issue":"6","key":"6876_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.7150\/jca.14208","volume":"7","author":"Y Kimura","year":"2016","unstructured":"Kimura Y, Kasamatsu A, Nakashima D, Yamatoji M, Minakawa Y, Koike K, Fushimi K, Higo M, Endo-Sakamoto Y, Shiiba M et al (2016) ARNT2 regulates tumoral growth in oral squamous cell carcinoma. J Cancer 7(6):702\u2013710","journal-title":"J Cancer"},{"issue":"2","key":"6876_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K (2019) Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov 9(2):176\u2013198","journal-title":"Cancer Discov"},{"key":"6876_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092392","author":"GK Gupta","year":"2020","unstructured":"Gupta GK, Collier AL, Lee D, Hoefer RA, Zheleva V, Siewertsz VRL, Tang-Tan AM, Guye ML, Chang DZ, Winston JS et al (2020) Perspectives on triple-negative breast cancer: current treatment strategies, Unmet needs, and potential targets for future therapies. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12092392","journal-title":"Cancers (Basel)"},{"issue":"3","key":"6876_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","volume":"157","author":"ML Suva","year":"2014","unstructured":"Suva ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV et al (2014) Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157(3):580\u2013594","journal-title":"Cell"},{"issue":"2","key":"6876_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-017-1783-x","volume":"135","author":"A Bogeas","year":"2018","unstructured":"Bogeas A, Morvan-Dubois G, El-Habr EA, Lejeune FX, Defrance M, Narayanan A, Kuranda K, Burel-Vandenbos F, Sayd S, Delaunay V et al (2018) Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness. Acta Neuropathol 135(2):267\u2013283","journal-title":"Acta Neuropathol"},{"issue":"1","key":"6876_CR29","doi-asserted-by":"publisher","first-page":"10909","DOI":"10.1038\/s41598-017-11366-y","volume":"7","author":"JL Simmons","year":"2017","unstructured":"Simmons JL, Pierce CJ, Al-Ejeh F, Boyle GM (2017) MITF and BRN2 contribute to metastatic growth after dissemination of melanoma. Sci Rep 7(1):10909","journal-title":"Sci Rep"},{"issue":"3","key":"6876_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10549-007-9739-9","volume":"110","author":"V Martinez","year":"2008","unstructured":"Martinez V, Kennedy S, Doolan P, Gammell P, Joyce H, Kenny E, Prakash MJ, Ryan E, O\u2019Connor R, Crown J et al (2008) Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue. Breast Cancer Res Treat 110(3):521\u2013530","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"6876_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrm2882","volume":"11","author":"B Vanhaesebroeck","year":"2010","unstructured":"Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11(5):329\u2013341","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6876_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1748-717X-4-43","volume":"4","author":"HF Li","year":"2009","unstructured":"Li HF, Kim JS, Waldman T (2009) Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells. Radiat Oncol 4:43","journal-title":"Radiat Oncol"},{"key":"6876_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.415","volume":"5","author":"L Chang","year":"2014","unstructured":"Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y (2014) PI3K\/Akt\/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways. Cell Death Dis 5:e1437","journal-title":"Cell Death Dis"},{"issue":"6","key":"6876_CR34","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/JTO.0b013e3181a1084f","volume":"4","author":"OC Schuurbiers","year":"2009","unstructured":"Schuurbiers OC, Kaanders JH, van der Heijden HF, Dekhuijzen RP, Oyen WJ, Bussink J (2009) The PI3-K\/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer. J Thorac Oncol 4(6):761\u2013767","journal-title":"J Thorac Oncol"},{"issue":"3","key":"6876_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.critrevonc.2015.07.005","volume":"96","author":"L Chang","year":"2015","unstructured":"Chang L, Graham PH, Ni J, Hao J, Bucci J, Cozzi PJ, Li Y (2015) Targeting PI3K\/Akt\/mTOR signaling pathway in the treatment of prostate cancer radioresistance. Crit Rev Oncol Hematol 96(3):507\u2013517","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1\u20132","key":"6876_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11010-018-3376-y","volume":"450","author":"Y Jia","year":"2019","unstructured":"Jia Y, Hao S, Jin G, Li H, Ma X, Zheng Y, Xiao D, Wang Y (2019) Overexpression of ARNT2 is associated with decreased cell proliferation and better prognosis in gastric cancer. Mol Cell Biochem 450(1\u20132):97\u2013103","journal-title":"Mol Cell Biochem"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06876-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-06876-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06876-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T15:09:56Z","timestamp":1679584196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-06876-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["6876"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-06876-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2292759\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of Nanfang Hospital and obeyed the rules required by the Guide for the Care and Use of Laboratory Animals. Registration No. of the study: NFYY-2021-0831 (The review list of the animal ethic committee to the animal protocol has been uploaded).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}